862P Neoadjuvant Chemo-Immunotherapy Using Carboplatin, Nab-Paclitaxel, Oral Metronomic Therapy and Low Dose Nivolumab for “borderline Resectable” Oral Cavity Carcinoma: A Prospective Phase II Single-Arm Trial (Neolocus)

P.K. Marimuthu,A.J. Tirkey, S. Sahu,A.O. John,J.T. Georgy,D.B. Thumaty, J. Riju, V. Konduru, M. Agrawal,B.K. Sasidharan, M. Mathew, S.K. Sidhique,A. Joel,R.T. Chacko,P. Jambunathan, K. Harikrishna, M. Thomas,J. Rani, A. Singh

Annals of Oncology（2024）

Cited 0|Views3

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined